Name: Unicycive Therapeutics, Inc. (UNCY) Financial Statements
Creator: FinSpry

Unicycive Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Unicycive Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.68	0.95	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.68	0.95	0.00	0.00
Operating Expenses
Research & Development	20.01	12.90	12.44	6.08	1.02
Selling, General & Administrative	12.10	8.55	6.57	2.90	1.01
Operating Expenses	32.12	21.45	19.00	8.98	2.02
Operating Income	-32.12	-20.77	-18.05	-8.98	-2.02
Other Income/Expense
Interest Income	1.26	0.62	0.00	0.00	0.00
Interest Expense	0.07	0.08	0.01	0.63	-0.24
Other Income/Expense	-4.61	-10.30	0.00	-0.41	0.00
Income
Income Before Tax	-36.73	-30.54	-18.06	-10.02	-2.26
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-36.73	-30.54	-18.06	-10.02	-2.26
Net Income - Continuous Operations	-36.73	-30.54	-18.06	-10.02	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-36.23	-30.18	-17.89	-9.38	0.00
EBIT	-32.12	-30.46	-18.05	-9.39	-2.02
Depreciation & Amortization	0.43	0.28	0.16	0.01	0.00
Earnings Per Share
Basic EPS	-6.00	-13.00	-12.00	-9.00	-3.00
Diluted EPS	-6.00	-13.00	-12.00	-9.00	-3.00
Basic Shares Outstanding	6.70	2.45	1.51	1.17	0.85
Diluted Shares Outstanding	6.70	2.45	1.51	1.17	0.85